Recognition of immune reactive proteins as a potential multiepitope vaccine candidate of Taenia solium cysticerci through proteomic approach
Journal of Cellular Biochemistry · 2023
DOI: 10.1002/jcb.30467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2023. Verfasst von Rimanpreet Kaur und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India. Hauptthemen laut MEDLINE: Taenia solium, Proteomics, Neurocysticercosis, Epitopes, B-Lymphocyte. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India, Indian Institute of Technology Mandi.
Abstract (Originalsprache)
Metacestode, the larva of Taenia solium , is the causative agent for neurocysticercosis (NCC), which causes epilepsy. The unavailability of a vaccine against human NCC is a major cause for its widespread prevalence across the globe. Therefore, the development of a reliable vaccine against NCC is the need of the hour. Employing a combination of proteomics and immunoinformatics, we endeavored to formulate a vaccine candidate. The immune reactive cyst fluid antigens of T. solium were identified by immune‐blotting two‐dimensional gels with NCC patient's sera, followed by Matrix‐assisted laser desorption‐ionization analysis. We performed a detailed proteomic study of these immune reactive proteins by utilizing immune‐informatics tools, identified the nontoxic, nonallergic, B‐cell epitopes, and collected epitopes with the least sequence homology with human and other Taenia species. These epitopes were joined through linkers to construct a multiepitope vaccine. Different physiochemical parameters such as molecular weight (23.82 kDa), instability (39.91), and aliphatic index (49.61) were calculated to ensure the stability of the linked peptides vaccine. The vaccine demonstrated stable interactions with different immune receptors like Toll‐like receptor 4 and IgG confirming that it will effectively stimulate the host immune response. We anticipate that our designed B‐cell linear epitope‐based vaccine will show promising results in in vitro and in vivo assays. This study provides a platform that would be useful to develop other suitable vaccine candidates to prevent helminthic neglected tropical diseases in near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.
- Dayanad Medical College and Hospital, Ludhiana, Punjab, India.
- CSIR-Institute for Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India.
- Indian Knowledge System and Mental Health Center, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.
ORCID-Profile: Amit Prasad
Förderung
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Institute of Technology Mandi
- DBT India and CSIR
Zitieren
APA
Kaur, R., Arora, N., Rawat, S. S., Keshri, A. K., Singh, G., Kumar, R., & Prasad, A. (2023). Recognition of immune reactive proteins as a potential multiepitope vaccine candidate of Taenia solium cysticerci through proteomic approach. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30467
Vancouver
Kaur R, Arora N, Rawat SS, Keshri AK, Singh G, Kumar R, et al. Recognition of immune reactive proteins as a potential multiepitope vaccine candidate of Taenia solium cysticerci through proteomic approach. Journal of Cellular Biochemistry. 2023. doi:10.1002/jcb.30467
BibTeX
@article{Kaur2023,
author = {Kaur, Rimanpreet and Arora, Naina and Rawat, Suraj S and Keshri, Anand K and Singh, Gagandeep and Kumar, Rajiv and Prasad, Amit},
title = {Recognition of immune reactive proteins as a potential multiepitope vaccine candidate of Taenia solium cysticerci through proteomic approach},
journal = {Journal of Cellular Biochemistry},
year = {2023},
doi = {10.1002/jcb.30467}
}
EUVIMED